{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:41:08Z","timestamp":1793407268324,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:00:00Z","timestamp":1758153600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:00:00Z","timestamp":1758153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS J"],"DOI":"10.1208\/s12248-025-01128-4","type":"journal-article","created":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T15:59:20Z","timestamp":1758211160000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Advanced P407\/Tw80\/\u03b2CD based Nasal Powders of Ropinirole Hydrochloride for Nose-to-Brain Delivery in Parkinson\u2019s Disease: Preparation and Comprehensive In Vitro and Ex Vivo Evaluation"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0263-4990","authenticated-orcid":false,"given":"Elmina-Marina","family":"Saitani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0566-0713","authenticated-orcid":false,"given":"Paraskevi","family":"Papakyriakopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0599-7490","authenticated-orcid":false,"given":"Stefanos","family":"Kikionis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1197-9010","authenticated-orcid":false,"given":"Natassa","family":"Pippa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5347-7430","authenticated-orcid":false,"given":"Stergios","family":"Pispas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2395-6844","authenticated-orcid":false,"given":"Georgia","family":"Valsami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,18]]},"reference":[{"issue":"5","key":"1128_CR1","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","volume":"20","author":"E Tolosa","year":"2021","unstructured":"Tolosa E, Garrido A, Scholz SW, Poewe W. Challenges in the diagnosis of Parkinson\u2019s disease. Lancet Neurol. 2021;20(5):385\u201397. https:\/\/doi.org\/10.1016\/S1474-4422(21)00030-2.","journal-title":"Lancet Neurol"},{"issue":"5","key":"1128_CR2","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","volume":"18","author":"GBD 2016 Neurology Collaborators","year":"2019","unstructured":"GBD 2016 Neurology Collaborators. Global, regional, and national burden of neurological disorders, 1990\u20132016: a systematic analysis for the Global burden of Disease study 2016. Lancet Neurol. 2019;18(5):459\u201380. https:\/\/doi.org\/10.1016\/S1474-4422(18)30499-X.","journal-title":"Lancet Neurol"},{"issue":"s1","key":"1128_CR3","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.3233\/JPD-181474","volume":"8","author":"ER Dorsey","year":"2018","unstructured":"Dorsey ER, Sherer T, Okun MS, Bloem BR. The emerging evidence of the Parkinson pandemic. J Parkinsons Dis. 2018;8(s1):S3\u20138. https:\/\/doi.org\/10.3233\/JPD-181474.","journal-title":"J Parkinsons Dis"},{"issue":"1","key":"1128_CR4","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1080\/10717544.2017.1359862","volume":"24","author":"E Barcia","year":"2017","unstructured":"Barcia E, Boeva L, Garc\u00eda-Garc\u00eda L, Slowing K, Fern\u00e1ndez-Carballido A, Casanova Y, et al. Nanotechnology-based drug delivery of ropinirole for Parkinson\u2019s disease. Drug Deliv. 2017;24(1):1112\u201323. https:\/\/doi.org\/10.1080\/10717544.2017.1359862.","journal-title":"Drug Deliv"},{"issue":"4","key":"1128_CR5","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1586\/14737175.4.4.581","volume":"4","author":"R Pahwa","year":"2004","unstructured":"Pahwa R, Lyons KE, Hauser RA. Ropinirole therapy for Parkinson\u2019s disease. Expert Rev Neurother. 2004;4(4):581\u20138. https:\/\/doi.org\/10.1586\/14737175.4.4.581.","journal-title":"Expert Rev Neurother"},{"issue":"2","key":"1128_CR6","first-page":"252","volume":"6","author":"A Misra","year":"2003","unstructured":"Misra A, Ganesh S, Shahiwala A, Shah SP. Drug delivery to the central nervous system: a review. J Pharm Pharm Sci. 2003;6(2):252\u201373.","journal-title":"J Pharm Pharm Sci"},{"key":"1128_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4137\/PMC.S13384","volume":"6","author":"JL Mikitsh","year":"2014","unstructured":"Mikitsh JL, Chacko AM. Pathways for small molecule delivery to the central nervous system across the blood-brain barrier. Perspect Medicin Chem. 2014;6:11\u201324. https:\/\/doi.org\/10.4137\/PMC.S13384.","journal-title":"Perspect Medicin Chem"},{"issue":"1","key":"1128_CR8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.pharmthera.2004.08.001","volume":"104","author":"DJ Begley","year":"2004","unstructured":"Begley DJ. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities. Pharmacol Ther. 2004;104(1):29\u201345. https:\/\/doi.org\/10.1016\/j.pharmthera.2004.08.001.","journal-title":"Pharmacol Ther"},{"issue":"3","key":"1128_CR9","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s002329900434","volume":"165","author":"H Fischer","year":"1998","unstructured":"Fischer H, Gottschlich R, Seelig A. Blood-brain barrier permeation: molecular parameters governing passive diffusion. J Membr Biol. 1998;165(3):201\u201311. https:\/\/doi.org\/10.1007\/s002329900434.","journal-title":"J Membr Biol"},{"issue":"4","key":"1128_CR10","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1602\/neurorx.2.4.541","volume":"2","author":"H Pajouhesh","year":"2005","unstructured":"Pajouhesh H, Lenz GR. Medicinal chemical properties of successful central nervous system drugs. NeuroRx. 2005;2(4):541\u201353. https:\/\/doi.org\/10.1602\/neurorx.2.4.541.","journal-title":"NeuroRx"},{"issue":"25","key":"1128_CR11","doi-asserted-by":"publisher","first-page":"6338","DOI":"10.1021\/jm049717d","volume":"47","author":"PD Leeson","year":"2004","unstructured":"Leeson PD, Davis AM. Time-related differences in the physical property profiles of oral drugs. J Med Chem. 2004;47(25):6338\u201348. https:\/\/doi.org\/10.1021\/jm049717d.","journal-title":"J Med Chem"},{"key":"1128_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.121016","volume":"607","author":"P Papakyriakopoulou","year":"2021","unstructured":"Papakyriakopoulou P, Manta K, Kostantini C, Kikionis S, Banella S, Ioannou E, et al. Nasal powders of quercetin-\u03b2-cyclodextrin derivatives complexes with mannitol\/lecithin microparticles for nose-to-brain delivery: in vitro and ex vivo evaluation. Int J Pharm. 2021;607:121016. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.121016.","journal-title":"Int J Pharm"},{"issue":"9","key":"1128_CR13","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3109\/1061186X.2015.1020809","volume":"23","author":"AD Kulkarni","year":"2015","unstructured":"Kulkarni AD, Vanjari YH, Sancheti KH, Belgamwar VS, Surana SJ, Pardeshi CV. Nanotechnology-mediated nose to brain drug delivery for Parkinson\u2019s disease: a mini review. J Drug Target. 2015;23(9):775\u201388. https:\/\/doi.org\/10.3109\/1061186X.2015.1020809.","journal-title":"J Drug Target"},{"issue":"3","key":"1128_CR14","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3390\/pharmaceutics13030385","volume":"13","author":"M Trenkel","year":"2021","unstructured":"Trenkel M, Scherlie\u00df R. Nasal powder formulations: in-vitro characterisation of the impact of powders on nasal residence time and sensory effects. Pharmaceutics. 2021;13(3):385. https:\/\/doi.org\/10.3390\/pharmaceutics13030385.","journal-title":"Pharmaceutics"},{"issue":"2","key":"1128_CR15","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.jconrel.2012.02.028","volume":"161","author":"F Buttini","year":"2012","unstructured":"Buttini F, Colombo P, Rossi A, Sonvico F, Colombo G. Particles and powders: tools of innovation for non-invasive drug administration. J Control Release. 2012;161(2):693\u2013702. https:\/\/doi.org\/10.1016\/j.jconrel.2012.02.028.","journal-title":"J Control Release"},{"key":"1128_CR16","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.ejps.2017.09.027","volume":"113","author":"L Tiozzo Fasiolo","year":"2018","unstructured":"Tiozzo Fasiolo L, Manniello MD, Tratta E, Buttini F, Rossi A, Sonvico F, et al. Opportunity and challenges of nasal powders: drug formulation and delivery. Eur J Pharm Sci. 2018;113:2\u201317. https:\/\/doi.org\/10.1016\/j.ejps.2017.09.027.","journal-title":"Eur J Pharm Sci"},{"key":"1128_CR17","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.ejps.2016.09.028","volume":"96","author":"A Tanaka","year":"2017","unstructured":"Tanaka A, Furubayashi T, Tomisaki M, Kawakami M, Kimura S, Inoue D, et al. Nasal drug absorption from powder formulations: the effect of three types of hydroxypropyl cellulose (HPC). Eur J Pharm Sci. 2017;96:284\u20139. https:\/\/doi.org\/10.1016\/j.ejps.2016.09.028.","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"1128_CR18","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1080\/10717544.2018.1428242","volume":"25","author":"A Giuliani","year":"2018","unstructured":"Giuliani A, Balducci AG, Zironi E, Colombo G, Bortolotti F, Lorenzini L, et al. In vivo nose-to-brain delivery of the hydrophilic antiviral ribavirin by microparticle agglomerates. Drug Deliv. 2018;25(1):376\u201387. https:\/\/doi.org\/10.1080\/10717544.2018.1428242.","journal-title":"Drug Deliv"},{"key":"1128_CR19","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jconrel.2021.05.020","volume":"335","author":"E Truzzi","year":"2021","unstructured":"Truzzi E, Rustichelli C, de Oliveira Junior ER, Ferraro L, Maretti E, Graziani D, et al. Nasal biocompatible powder of Geraniol oil complexed with cyclodextrins for neurodegenerative diseases: physicochemical characterization and in vivo evidences of nose to brain delivery. J Control Release. 2021;335:191\u2013202. https:\/\/doi.org\/10.1016\/j.jconrel.2021.05.020.","journal-title":"J Control Release"},{"key":"1128_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.122038","volume":"624","author":"M Perku\u0161i\u0107","year":"2022","unstructured":"Perku\u0161i\u0107 M, Ni\u017ei\u0107 Nodilo L, Ugrina I, \u0160poljari\u0107 D, Jakobu\u0161i\u0107 Brala C, Pepi\u0107 I, et al. Tailoring functional spray-dried powder platform for efficient donepezil nose-to-brain delivery. Int J Pharm. 2022;624:122038. https:\/\/doi.org\/10.1016\/j.ijpharm.2022.122038.","journal-title":"Int J Pharm"},{"key":"1128_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120827","volume":"605","author":"L Tiozzo Fasiolo","year":"2021","unstructured":"Tiozzo Fasiolo L, Manniello MD, Banella S, Napoli L, Bortolotti F, Quarta E, et al. Flurbiprofen sodium microparticles and soft pellets for nose-to-brain delivery: serum and brain levels in rats after nasal insufflation. Int J Pharm. 2021;605:120827. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120827.","journal-title":"Int J Pharm"},{"key":"1128_CR22","doi-asserted-by":"publisher","DOI":"10.1515\/ntrev-2023-0204","author":"E-M Saitani","year":"2024","unstructured":"Saitani E-M, Selianitis D, Pippa N, Pispas S, Valsami G. Cyclodextrins-block copolymer drug delivery systems: from design and development to preclinical studies. Nanotechnol Rev. 2024. https:\/\/doi.org\/10.1515\/ntrev-2023-0204.","journal-title":"Nanotechnol Rev"},{"issue":"2","key":"1128_CR23","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.3390\/ijms25021162","volume":"25","author":"E-M Saitani","year":"2024","unstructured":"Saitani E-M, Pippa N, Perinelli DR, Forys A, Papakyriakopoulou P, Lagopati N, et al. Fabricating polymer\/surfactant\/cyclodextrin hybrid particles for possible nose-to-brain delivery of ropinirole hydrochloride. In vitro and ex vivo evaluation. Int J Mol Sci. 2024;25(2):1162. https:\/\/doi.org\/10.3390\/ijms25021162.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1128_CR24","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ijpharm.2012.09.049","volume":"440","author":"AG Balducci","year":"2013","unstructured":"Balducci AG, Ferraro L, Bortolotti F, Nastruzzi C, Colombo P, Sonvico F, et al. Antidiuretic effect of desmopressin chimera agglomerates by nasal administration in rats. Int J Pharm. 2013;440(2):154\u201360. https:\/\/doi.org\/10.1016\/j.ijpharm.2012.09.049.","journal-title":"Int J Pharm"},{"issue":"10","key":"1128_CR25","doi-asserted-by":"publisher","first-page":"988","DOI":"10.3390\/pharmaceutics12100988","volume":"12","author":"L de Souza Teixeira","year":"2020","unstructured":"de Souza Teixeira L, Vila Chagas T, Alonso A, Gonzalez-Alvarez I, Bermejo M, Polli J, et al. Biomimetic artificial membrane permeability assay over Franz cell apparatus using BCS model drugs. Pharmaceutics. 2020;12(10):988. https:\/\/doi.org\/10.3390\/pharmaceutics12100988.","journal-title":"Pharmaceutics"},{"issue":"1","key":"1128_CR26","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ijpharm.2016.07.002","volume":"514","author":"G Colombo","year":"2016","unstructured":"Colombo G, Bortolotti F, Chiapponi V, Buttini F, Sonvico F, Invernizzi R, et al. Nasal powders of thalidomide for local treatment of nose bleeding in persons affected by hereditary hemorrhagic telangiectasia. Int J Pharm. 2016;514(1):229\u201337. https:\/\/doi.org\/10.1016\/j.ijpharm.2016.07.002.","journal-title":"Int J Pharm"},{"issue":"9","key":"1128_CR27","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1080\/1061186X.2019.1574300","volume":"27","author":"L Tiozzo Fasiolo","year":"2019","unstructured":"Tiozzo Fasiolo L, Manniello MD, Bortolotti F, Buttini F, Rossi A, Sonvico F, et al. Anti-inflammatory flurbiprofen nasal powders for nose-to-brain delivery in Alzheimer\u2019s disease. J Drug Target. 2019;27(9):984\u201394. https:\/\/doi.org\/10.1080\/1061186X.2019.1574300.","journal-title":"J Drug Target"},{"issue":"4","key":"1128_CR28","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1248\/bpb.b14-00398","volume":"38","author":"S Gizurarson","year":"2015","unstructured":"Gizurarson S. The effect of cilia and the mucociliary clearance on successful drug delivery. Biol Pharm Bull. 2015;38(4):497\u2013506. https:\/\/doi.org\/10.1248\/bpb.b14-00398.","journal-title":"Biol Pharm Bull"},{"key":"1128_CR29","unstructured":"U.S. Food and Drug Administration (FDA). Guidance for Industry #292: Chemistry, manufacturing, and controls considerations for Type A medicated articles. U.S. Department of Health and Human Services. 2023.\u00a0https:\/\/www.fda.gov\/media\/179219\/download. Accessed\u00a0June 2024"},{"key":"1128_CR30","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1208\/s12249-012-9815-2","volume":"13","author":"R Capen","year":"2012","unstructured":"Capen R, Christopher D, Forenzo P, Ireland C, Liu O. On the shelf life of pharmaceutical products. AAPS PharmSciTech. 2012;13:911\u20138. https:\/\/doi.org\/10.1208\/s12249-012-9815-2.","journal-title":"AAPS PharmSciTech"},{"issue":"5","key":"1128_CR31","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1208\/s12249-016-0653-5","volume":"18","author":"PM Kashif","year":"2017","unstructured":"Kashif PM, Madni A, Ashfaq M, Rehman M, Mahmood MA, Khan MI, et al. Development of Eudragit RS 100 microparticles loaded with ropinirole: optimization and in vitro evaluation studies. AAPS PharmSciTech. 2017;18(5):1810\u201322. https:\/\/doi.org\/10.1208\/s12249-016-0653-5.","journal-title":"AAPS PharmSciTech"},{"issue":"3","key":"1128_CR32","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1080\/10837450.2019.1567762","volume":"25","author":"N Hussein","year":"2020","unstructured":"Hussein N, Omer H, Ismael A, Albed Alhnan M, Elhissi A, Ahmed W. Spray-dried alginate microparticles for potential intranasal delivery of ropinirole hydrochloride: development, characterization and histopathological evaluation. Pharm Dev Technol. 2020;25(3):290\u20139. https:\/\/doi.org\/10.1080\/10837450.2019.1567762.","journal-title":"Pharm Dev Technol"},{"key":"1128_CR33","doi-asserted-by":"publisher","unstructured":"Stillwell W. An Introduction to Biological Membranes (Second Edition) - Membrane Transport. Elservier. 2016;19:429\u2013451. https:\/\/doi.org\/10.1016\/B978-0-444-63772-7.00019-1.","DOI":"10.1016\/B978-0-444-63772-7.00019-1"},{"issue":"8","key":"1128_CR34","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.3390\/pharmaceutics13081180","volume":"13","author":"G Rassu","year":"2021","unstructured":"Rassu G, Sorrenti M, Catenacci L, Pavan B, Ferraro L, Gavini E, et al. Versatile nasal application of cyclodextrins: excipients and\/or actives? Pharmaceutics. 2021;13(8):1180. https:\/\/doi.org\/10.3390\/pharmaceutics13081180.","journal-title":"Pharmaceutics"},{"key":"1128_CR35","doi-asserted-by":"publisher","first-page":"1068495","DOI":"10.3389\/fphar.2022.1068495","volume":"13","author":"J Maeng","year":"2022","unstructured":"Maeng J, Lee K. Systemic and brain delivery of antidiabetic peptides through nasal administration using cell-penetrating peptides. Front Pharmacol. 2022;13:1068495. https:\/\/doi.org\/10.3389\/fphar.2022.1068495.","journal-title":"Front Pharmacol"},{"issue":"27","key":"1128_CR36","doi-asserted-by":"publisher","first-page":"6587","DOI":"10.1039\/d4tb00489b","volume":"12","author":"E-M Saitani","year":"2024","unstructured":"Saitani E-M, Pippa N, Perinelli DR, Forys A, Papakyriakopoulou P, Lagopati N, et al. PEO-b-PCL\/Tween 80\/cyclodextrin systems: from bioinspired fabrication to possible nasal administration of ropinirole hydrochloride. J Mater Chem B. 2024;12(27):6587\u2013604. https:\/\/doi.org\/10.1039\/d4tb00489b.","journal-title":"J Mater Chem B"},{"key":"1128_CR37","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.msec.2015.11.028","volume":"59","author":"C Karavasili","year":"2016","unstructured":"Karavasili C, Bouropoulos N, Sygellou L, Amanatiadou EP, Vizirianakis IS, Fatouros DG. PLGA\/DPPC\/trimethylchitosan spray-dried microparticles for the nasal delivery of ropinirole hydrochloride: in vitro, ex vivo and cytocompatibility assessment. Mater Sci Eng C Mater Biol Appl. 2016;59:1053\u201362. https:\/\/doi.org\/10.1016\/j.msec.2015.11.028.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"1128_CR38","doi-asserted-by":"publisher","DOI":"10.4236\/jeas.2019.92005","author":"S Ibrahim","year":"2019","unstructured":"Ibrahim S, Bowra S. Improving oxidative stability of polyphenolic fraction of apple pomace by encapsulation using naturally occurring polymers. J Encapsulation Adsorpt Sci. 2019. https:\/\/doi.org\/10.4236\/jeas.2019.92005.","journal-title":"J Encapsulation Adsorpt Sci"},{"issue":"6","key":"1128_CR39","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1002\/jps.2600720614","volume":"72","author":"MJ Pikal","year":"1983","unstructured":"Pikal MJ, Shah S, Senior D, Lang JE. Physical chemistry of freeze-drying: measurement of sublimation rates for frozen aqueous solutions by a microbalance technique. J Pharm Sci. 1983;72(6):635\u201350. https:\/\/doi.org\/10.1002\/jps.2600720614.","journal-title":"J Pharm Sci"},{"issue":"7","key":"1128_CR40","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s12272-012-0709-3","volume":"35","author":"KR Chu","year":"2012","unstructured":"Chu KR, Lee E, Jeong SH, Park ES. Effect of particle size on the dissolution behaviors of poorly water-soluble drugs. Arch Pharm Res. 2012;35(7):1187\u201395. https:\/\/doi.org\/10.1007\/s12272-012-0709-3.","journal-title":"Arch Pharm Res"},{"issue":"3","key":"1128_CR41","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3390\/pharmaceutics10030074","volume":"10","author":"X Zhang","year":"2018","unstructured":"Zhang X, Xing H, Zhao Y, Ma Z. Pharmaceutical dispersion techniques for dissolution and bioavailability enhancement of poorly water-soluble drugs. Pharmaceutics. 2018;10(3):74. https:\/\/doi.org\/10.3390\/pharmaceutics10030074.","journal-title":"Pharmaceutics"}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-025-01128-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12248-025-01128-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-025-01128-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T17:58:44Z","timestamp":1762192724000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12248-025-01128-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,18]]},"references-count":41,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["1128"],"URL":"https:\/\/doi.org\/10.1208\/s12248-025-01128-4","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,18]]},"assertion":[{"value":"12 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional Review Board"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"The authors report no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"143"}}